BRCA1:不活化的机制和对患者管理的影响
Richard D Kennedy1, Jennifer E Quinn, Patrick G Johnston
1Department of Oncology, Cancer Research Centre, Queen's University Belfast, BT9 7AB, Northern Ireland, Belfast, Ireland.
了解BRCA1基因突变对于早期发现乳腺癌和卵巢癌至关重要. 本综述探讨了BRCA1无活化如何影响癌症预防,预后和治疗反应.
科学领域:
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 1994年发现的BRCA1基因与遗传性乳腺癌和卵巢癌有关.
- 基因检测可以识别患上这些癌症的高风险个体.
- 由于BRCA1无活化导致恶性瘤的确切机制尚未完全理解.
研究的目的:
- 检查BRCA1无活化的机制.
- 评估这些机制对患者管理的影响,包括癌症预防策略.
- 评估BRCA1作为预后和预测标记物的实用性.
主要方法:
- 关于BRCA1基因功能和失活的文献综述.
- 对受BRCA1.1影响的细胞通路的分析.
- 功能后果与突变载体临床观察的相关性.
主要成果:
- BRCA1参与关键的细胞通路,如DNA修复和转录调节.
- 研究了失活机制及其临床影响.
- 讨论了BRCA1作为预后和预测生物标志物的潜力.
结论:
- BRCA1 失活对癌症的发展和患者的结果有重大影响.
- 了解这些机制可以完善癌症预防和治疗策略.
- 作为预测预后和治疗反应的工具,BRCA1具有前景.
更多相关视频
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
09:24Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
